Stock Earnings

Question 1

BioNexus Gene Lab Corp'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, BioNexus Gene Lab Corp'in toplam varlıkları $10 olup, net loss $-1'dir.

Question 2

BGLC'ün temel finansal oranları nelerdir?

Accepted Answer

BioNexus Gene Lab Corp'in cari oranı 5, net kâr marjı -11.11, hisse başına satış $5.05'dir.

Question 3

BioNexus Gene Lab Corp'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

BioNexus Gene Lab Corp largest revenue segment is Trading of Industrial Chemicals, at a revenue of 9,494,577 in the most earnings release.For geography, Malaysia is the primary market for BioNexus Gene Lab Corp, at a revenue of 7,455,906.

Question 4

BioNexus Gene Lab Corp kârlı mı?

Accepted Answer

no, son mali tablolara göre BioNexus Gene Lab Corp'in net loss $-1'dir.

Question 5

BioNexus Gene Lab Corp'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, BioNexus Gene Lab Corp'in yükümlülüğü 2'dir.

Question 6

BioNexus Gene Lab Corp'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

BioNexus Gene Lab Corp'in toplam tedavüldeki hisse sayısı 1.79'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	9	9	9	10	13	11
Revenue Growth (YoY)	0%	0%	-10%	-23%	18%	--
Cost of Revenue	8	8	8	9	11	9
Gross Profit	1	1	1	1	2	1
Selling, General & Admin	5	3	4	1	1	1
Research & Development	--	0	0	--	--	--
Operating Expenses	4	2	3	1	1	0
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-3	-1	-2	0	1	1
Income Tax Expense	0	0	0	0	0	0
Net Income	-2	-1	-2	0	0	1
Net Income Growth	0%	-50%	--	--	-100%	--
Shares Outstanding (Diluted)	1.79	1.78	1.58	1.44	1.42	0.85
Shares Change (YoY)	2%	12%	10%	1%	66%	19%
EPS (Diluted)	-1.63	-0.9	-1.66	-0.24	0.52	1.27
EPS Growth	31%	-46%	592%	-146%	-59%	-474%
Free Cash Flow	-3	-2	-1	0	0	0
Free Cash Flow Per Share	-1.66	-1.12	-0.62	0	0	0
Gross Margin	11.11%	11.11%	11.11%	10%	15.38%	9.09%
Operating Margin	-22.22%	-11.11%	-22.22%	0%	7.69%	9.09%
Profit Margin	-22.22%	-11.11%	-22.22%	0%	0%	9.09%
Free Cash Flow Margin	-33.33%	-22.22%	-11.11%	0%	0%	0%
EBITDA	-2	-1	-2	0	1	1
EBITDA Margin	-22.22%	-11.11%	-22.22%	0%	7.69%	9.09%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-2	-1	-2	0	1	1
EBIT Margin	-22.22%	-11.11%	-22.22%	0%	7.69%	9.09%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

BioNexus Gene Lab Corp (BGLC) Price

BGLC Stock Price Chart

BGLC Income

Follow-Up Questions